RadiotherapyRadiotherapy DosageRadiotherapy, AdjuvantRadiotherapy, ConformalRadiotherapy, Intensity-ModulatedCombined Modality TherapyRadiotherapy Planning, Computer-AssistedRadiotherapy, High-EnergyDose FractionationRadiation InjuriesRadiotherapy, Computer-AssistedRadiotherapy, Image-GuidedTumor BurdenTumor Markers, BiologicalBrain NeoplasmsTreatment OutcomeCell Line, TumorNeoplasm StagingTumor Necrosis Factor-alphaNeoplasm Recurrence, LocalRadiation OncologyHead and Neck NeoplasmsCarcinoma, Squamous CellRadiosurgeryDose-Response Relationship, RadiationWilms TumorAntineoplastic Combined Chemotherapy ProtocolsBrachytherapyRetrospective StudiesDisease-Free SurvivalSurvival RateNeoplasms, ExperimentalAdenocarcinomaSurvival AnalysisChemoradiotherapyNeoplasmsNasopharyngeal NeoplasmsTumor Suppressor Protein p53Radiation ToleranceLung NeoplasmsGenes, Tumor SuppressorRadiation-Sensitizing AgentsFollow-Up StudiesNeoplasm MetastasisBreast NeoplasmsCarcinoid TumorCisplatinPrognosisRectal NeoplasmsTime FactorsTomography, X-Ray ComputedChemotherapy, AdjuvantTumor Suppressor ProteinsNeuroendocrine TumorsGliomaOrgans at RiskTumor MicroenvironmentGlioblastomaNeovascularization, PathologicAntineoplastic AgentsMammary Neoplasms, ExperimentalNeoplasms, Radiation-InducedCranial IrradiationRadiometryParticle AcceleratorsXenograft Model Antitumor AssaysRadiation DosageLaryngeal NeoplasmsLymphatic MetastasisBone NeoplasmsTransplantation, HeterologousLiver NeoplasmsFluorouracilCell ProliferationNeoplasms, Second PrimaryVincristineDacarbazineRadiation PneumonitisNeoadjuvant TherapyHodgkin DiseaseCarcinoma, Non-Small-Cell LungMastectomy, SegmentalDisease ProgressionProstatic NeoplasmsSarcomaSkin NeoplasmsPancreatic NeoplasmsAstrocytomaSpinal NeoplasmsMice, Inbred BALB CDoxorubicinPelvic NeoplasmsKaplan-Meier EstimatePositron-Emission TomographyAntigens, NeoplasmKidney NeoplasmsRadiopharmaceuticalsNeoplasm ProteinsOrgan Sparing TreatmentsGastrointestinal Stromal Tumors